Moving Toward Precision Medicine Field is Growing Quickly Changes are Coming
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Moving Toward Precision Medicine | Field is Growing Quickly & Changes are Coming at Annual Meeting 2018
97 Views
5 years Ago
Bladder
UGN-102 - Top line Phase 3 study results - Mark Schoenberg, MD
39 Views
![Updates in GU [2023] Interview - Mar, MD - MOASC](https://oncologytubecom.cdn.ypt.me/videos/video_230901052308_vb702/video_230901052308_vb702_thumbsV2_jpg.webp?cache=1694006317_1694006317 "Updates in GU [2023] Interview - Mar, MD - MOASC")
Updates in GU [2023] Interview - Mar, MD - MOASC
Urothelial Cancer Eligibility: ASCO-FCR Recommendations - Dukkipati, MD - MOASC
Sacituzumab Govitecan: A New Dawn in Cancer Care
49 Views
Infigratinib: A Game Changer in Urothelial Carcinoma Therapy
24 Views
Sacituzumab Efficacy in LA or mUC Trop-2 Expression Results
36 Views
Sacituzumab Govitecan Status of the TROPHY-U-01 Cohort 1, a Phase 2 Study
171 Views
Understanding Pembrolizumab in Advanced Urothelial Carcinoma
13 Views
Urothelial Cancers Phase 3 Trial KEYNOTE-045 and KEYNOTE-361 Efficacy and Safety Results
42 Views
Urothelial Carcinoma PROOF 302: A phase III trial of Infigratinib in FGFR3 alterations
92 Views
Bladder Cancer Test: Does GALEAS Bladder aid in the early detection of bladder cancers? Prof. Bryan Dr. Ward
25 Views
Bladder Cancer Test: Does GALEAS Bladder aid in the early detection of bladder cancers? Prof. Bryan Dr. Ward
23 Views